title: The interaction of dipole modifiers with amphotericin-ergosterol complexes. Effects of phospholipid and sphingolipid membrane composition.
abstract: The influence of agents, known to affect the membrane dipole potential, phloretin and RH 421, on the multi channel activity of amphotericin B in lipid bilayers of various compositions, was studied. It was shown that the effects were dependent on the membrane's phospholipid and sphingolipid type. Phloretin enhanced amphotericin B induced steady-state transmembrane current through bilayers made from binary mixtures of POPC (DOPC) and ergosterol and ternary mixture of DPhPC, ergosterol and stearoylphytosphingosine. RH 421 increased steady-state polyene induced transmembrane current through membranes made from binary mixtures of DPhPC (DPhPS) and ergosterol and ternary mixture of DPhPS, ergosterol and stearoylphytosphingosine. It was proposed that the observed effects reflect the fine balance of the interactions between the various components present: amphotericin B, ergosterol, phospholipid, sphingolipid and dipole modifier. The shape of lipid molecules seems to be an important factor impacting the responses of amphotericin B modified bilayers to dipole modifiers. The influence of different phospholipids and sphingolipids on the physical and structural properties of ordered lipid microdomains, enriched in AmB, was also discussed. It was also shown that RH 421 enhanced the antifungal activity of amphotericin B in vitro.
authors.affiliation: Institute of Cytology of the Russian Academy of Sciences, Tikhoretsky ave. 4, St. Petersburg, 194064, Russia, ostroumova@mail.cytspb.rssi.ru.
authors.forename: Olga S
authors.initials: OS
authors.lastname: Ostroumova
authors.forename: Svetlana S
authors.initials: SS
authors.lastname: Efimova
authors.forename: Ekaterina V
authors.initials: EV
authors.lastname: Mikhailova
authors.forename: Ludmila V
authors.initials: LV
authors.lastname: Schagina
mesh_terms: D000666:Amphotericin B / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D002462:Cell Membrane / Q000737:chemistry* / Q000378:metabolism; D004347:Drug Interactions; D004875:Ergosterol / Q000378:metabolism*; D008051:Lipid Bilayers / Q000737:chemistry / Q000378:metabolism; D010693:Phloretin / Q000494:pharmacology*; D010743:Phospholipids; D011726:Pyridinium Compounds / Q000494:pharmacology*; D013107:Sphingolipids; D013343:Styrenes / Q000494:pharmacology*
chemical_list: D008051:Lipid Bilayers; D010743:Phospholipids; D011726:Pyridinium Compounds; D013107:Sphingolipids; D013343:Styrenes; C070534:RH 421; D000666:Amphotericin B; D010693:Phloretin; D004875:Ergosterol